Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
07/2003
07/22/2003US6596486 Methods and compositions pertaining to PD-Loops
07/22/2003US6596485 Fusion proteins capapble of presenting the peptide in a conformationally restricted form; use in screening peptide libraries
07/22/2003US6596484 Detection of differences and similarities in nucleotde sequences; obtain nucleotide sequences, incubate with endonuclease, insert nucleotide sequences, expose to primers, amplify, determine sequences, detect similarities
07/22/2003US6596480 Detection od apoptotic cells; obtain cell sample, fix, expose to ligase, detect ligate sequences, evaluate cell for apoptotic activity
07/22/2003US6596479 Methods and compositions for chromosome-specific staining
07/22/2003US6596477 Treatment and prevention of immunodeficiency virus infection by administration of non-pyrogenic derivatives of lipid A
07/22/2003US6596475 Protein conjugates containing multimers of green fluorescent protein
07/22/2003US6596474 Kit for use in the detection and treatment of nervous system disorders
07/22/2003US6596473 Detection of antiapotosis protein; obtain genetically engineered cells, measure viable cells, incubate with antiapoptosis agent, compare with control, evaluate adjustment in apoptosis activity
07/22/2003US6596257 In situ labeling of preferential tissues; obtain tissue, incubate with conjugate, monitor sample for visible signal
07/22/2003US6596179 Apparatus for the separation of biologic components from heterogeneous cell populations
07/22/2003US6596154 Nitrate concentration; "Migrational Sensitivity Control"; controlling net diffusion rate of electrically charged particles with an electrical potential difference between denitrifying bacteria area and the surrounding fluid; N2O
07/22/2003CA2198951C Method for end pointing enzyme detection methods
07/22/2003CA2109320C Peptide nucleic acids
07/22/2003CA2045891C Oligonucleotide analogs with terminal 3'-3' or 5'-5' internucleotide linkages
07/17/2003WO2003058500A1 Rna sequence analyzer, and rna sequence analysis method, program and recording medium
07/17/2003WO2003058252A2 Test strip for determining concentration of multiple analytes in a single fluid sample
07/17/2003WO2003058251A2 Toxicity test
07/17/2003WO2003058248A2 Diagnostics and vaccines for mycrobacterium paratuberculosis infections
07/17/2003WO2003058239A2 Test strip for determining concentration of triglycerides
07/17/2003WO2003058237A1 Sensors and methods of detection for proteinase enzymes
07/17/2003WO2003058233A1 Method of screening compound having fungal cell wall synthesis inhibitory activity
07/17/2003WO2003058228A1 Electrophoresis-use microchip
07/17/2003WO2003058201A2 Methods for identifying marker genes for cancer
07/17/2003WO2003058199A2 Arrays of microparticles and methods of preparation thereof
07/17/2003WO2003058196A2 Multianalyte molecular analysis using application-specific random particle arrays
07/17/2003WO2003058194A2 Affinity labeling of enzymes for detection of enzyme activity level in living cells
07/17/2003WO2003058193A2 Microarrays for cell phenotyping and manipulation
07/17/2003WO2003057927A2 Detection of human papillomavirus e6 mrna
07/17/2003WO2003057926A1 Gene products differentially expressed in cancerous breast cells and their methods of use
07/17/2003WO2003057925A1 Isoaspartyl repair
07/17/2003WO2003057923A1 Methods for mapping the chromosomal loci of genes expressed by a cell
07/17/2003WO2003057922A1 Articles of manufacture and methods for examining biochips using phase contrast optics
07/17/2003WO2003057920A1 Drug response marker in beta-1 adrenergic receptor gene
07/17/2003WO2003057919A2 The use of histamine h4 receptor antagonist for the treatment of inflammatory response
07/17/2003WO2003057918A1 Light-directed molecular analysis for cancer prognosis and diagnosis
07/17/2003WO2003057917A2 An isolated nucleotide sequence responsible for the tomato dark green (dg) mutation and uses thereof
07/17/2003WO2003057916A2 Cancer profiles
07/17/2003WO2003057915A2 Methods of detecting hcv genotype 1 (hcv-1) by using primers specific for the 5’ non-coding region (ncr) of the hcv genome
07/17/2003WO2003057914A2 METHOD FOR DETECTING HUMAN PAPILLOMAVIRUS mRNA
07/17/2003WO2003057913A2 Method for the detection and/or identification of the original animal species in animal matter contained in a sample
07/17/2003WO2003057912A2 Molecular trichogram
07/17/2003WO2003057911A2 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy
07/17/2003WO2003057910A2 Use of silica material in an amplification reaction
07/17/2003WO2003057909A2 Method for detecting cytosine-methylation patterns by exponential ligation of hybridised probe oligo-nucleotides (mla)
07/17/2003WO2003057908A2 Methods for detecting nucleic acids while using solid phase bound primers and cleaving the products of a cyclic amplification reaction (trap release primer amplification (tramp))
07/17/2003WO2003057903A2 New method for analyzing, detecting, and/or monitoring the microbiological quality of a gas, device for carrying out said method, and use of said device
07/17/2003WO2003057902A2 A method to assess quorum sensing potential of microbial communities
07/17/2003WO2003057901A2 Method for detecting nucleic acid molecules based on the relative movement of surfaces
07/17/2003WO2003057888A1 Cell-specific expression/replication vector
07/17/2003WO2003057880A1 Method of quantifying nucleic acid and kit for quantifying nucleic acid
07/17/2003WO2003057879A1 Novel udp-n-acetyl-d-galactosamine:polypeptide n-acetylgalactosamine transferase and nucleic acid encoding the same
07/17/2003WO2003057877A1 Characteristic base sequences occurring in plant genes and method of utilizing the same
07/17/2003WO2003057876A1 Method of screening multiple squamous carcinoma risk group
07/17/2003WO2003057874A1 Disease markers for renal diseaes and utilization thereof
07/17/2003WO2003057873A1 Plastic plate and plastic plate assembly
07/17/2003WO2003057870A1 Human phosphatidic acid phosphatase type 2-like protein
07/17/2003WO2003057868A1 Novel n-acetylglucosamines transferase and nucleic acids encoding the same
07/17/2003WO2003057858A2 Nucleic acid hybridization-based biosensing devices and methods utilizing intelligently-designed oligonucleotide probe sets
07/17/2003WO2003057854A2 Novel proteins and nucleic acids encoding same
07/17/2003WO2003057850A2 Binding proteins as biosensors
07/17/2003WO2003057845A2 Automated systems and methods for analysis of protein post-translational modification
07/17/2003WO2003057839A2 Compositions and methods relating to urinary specific genes and proteins
07/17/2003WO2003057835A2 Pak5-related compositions and methods
07/17/2003WO2003057832A2 Identification of genes controlling complex traits
07/17/2003WO2003057825A2 Gene expression patterns in response to atypical and typical neuroleptic agents in the central nervous system
07/17/2003WO2003057730A1 Ligand for g-protein coupled receptor gpr43 and uses thereof
07/17/2003WO2003057723A2 Fluorogenic protease substrates doubly labelled with rhodamine moieties
07/17/2003WO2003057718A2 Genetic analysis systems and methods
07/17/2003WO2003057258A2 Quantitative ranking of transient ligand binding to target biomolecules
07/17/2003WO2003057252A1 Human mast cell-expressed membrane proteins
07/17/2003WO2003057240A2 Treatment and diagnosis of af4-dependant diseases
07/17/2003WO2003057239A1 Polyphenol inhibition of nucleoside diphosphate kinase-b activity and cancer metastasis
07/17/2003WO2003057204A2 Modulation of iamt (pimt or pcmt) in immune system
07/17/2003WO2003057178A2 Viral capsid assembly intermediates
07/17/2003WO2003057168A2 Cancer-associated epitope
07/17/2003WO2003057165A2 COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF AMYLOID-β PEPTIDE-RELATED DISORDERS
07/17/2003WO2003057159A2 Psoriasin expression by breast epithelial cells
07/17/2003WO2003057148A2 Use of biomolecular targets in the treatment and visualization of tumors
07/17/2003WO2003057146A2 Novel compositions and methods for cancer
07/17/2003WO2003057130A2 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof
07/17/2003WO2003057014A2 Biomarkers for detecting ovarian cancer
07/17/2003WO2003057010A2 Droplet-based microfluidic oligonucleotide synthesis engine
07/17/2003WO2003057009A2 Genetic changes in atypical nodular proliferations in congenital melanocytic nevi
07/17/2003WO2003057007A2 System for monitoring bacterial tumor treatment
07/17/2003WO2003056912A2 Inducible transposition in transgenic organism using transposon vector
07/17/2003WO2003056896A2 Use of cytokines secreted by dendritic cells
07/17/2003WO2003045907A3 Sir2 products and activities
07/17/2003WO2003038401A3 Semiconductor nanocrystal-based cellular imaging
07/17/2003WO2003038046A3 Multiple oligonucleotides per gene for use in gene arrays
07/17/2003WO2003035902A3 Method for williams-beuren syndrome diagnosis
07/17/2003WO2003035838A3 Stem cells that transform to beating cardiomyocytes
07/17/2003WO2003031595A3 Molecules for disease detection and treatment
07/17/2003WO2003016550A3 Compositions and methods comprising control nucleic acid
07/17/2003WO2003012389A3 Method for analysing macromolecules, analysis device and a method for producing an analysis device
07/17/2003WO2003000896A3 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE
07/17/2003WO2002103045A3 Improvements in and relating to the provision of dna investigating tools
07/17/2003WO2002099124A3 Characterising polypeptides
07/17/2003WO2002099044A3 B3galts as modifiers of the p53 pathway and methods of use
07/17/2003WO2002083938A3 Screening methods for identifying ligands